Comparison of therapeutic responses of corticosteroid injection vs ultrasound in patients with plantar fasciitis.

Comparison of therapeutic responses of corticosteroid injection vs Extra-corporeal shock-wave treatment in patients with acute plantar fasciitis referred to Rasht Poursina hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108097274N1

Enrollment

Registered

2011-08-28

Start date

2011-07-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis. Plantar fascial fibromatosis Plantar fasciitis

Interventions

Intervention 1: For all intervention group patients, three sessions of shock-wave with 1500-2000 frequency and energy density of 0.15 mJ/mm2 with 1 week interval (total energy flux density dose: 900 m

Treatment - Devices

Treatment - Drugs

For all intervention group patients, three sessions of shock-wave with 1500-2000 frequency and energy density of 0.15 mJ/mm2 with 1 week interval (total energy flux density dose: 900 mJ/mm2) will be p

The orthopedist needles and injects mixture of 1cc of Methyl Prednisolon Acetate (40mg) and 1cc of 2% Lidocaine at maximal point tenderness from inferomedial aspect of calcaneal tuberosity in control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients with plantar fasciitis or calcaneal spur diagnosis refered to orthopedic clinic of Poursina Hospital in Rasht; Severe morning calcaneal pain which ameliorates after walking; Point tenderness on calcaneal tuberosity. Exclusion criteria: History of rheumatoid arthritis; Psycho-social problems; Diabetes mellitus; History of local injection and physiotherapy; Any bony lesion including fractures or tumors.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Therapeutic response (Rate of pain reduction). Timepoint: Pre-treatment, 3, 6 and 12 weeks post-treatment. Method of measurement: VAS score.	—

Secondary

Measure	Time frame
Recurrence rate. Timepoint: Recurrence rate. Method of measurement: VAS score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohsen Mardani Kivi

Guilan University of Medical Science

mardani@gums.ac.ir+98 13 1321 1470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026